| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/20/2010 | US7700655 Antiallergic agents |
| 04/20/2010 | US7700610 Use of tyrosine kinase inhibitors for treating allergic diseases |
| 04/20/2010 | US7700586 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 04/20/2010 | US7700558 Methods for treating diabetes using fibroblast growth factor-like polypeptides |
| 04/20/2010 | US7700317 glycoprotein comprising the extracellular domain of a non-naturally occurring BAFF-R; BAFF (B-cell-activating factor of the TNF family); immunologic, autoimmune diseases, cancers, virus-associated diseases, renal, hypertensive diseases, conditions requiring immunosuppression, inflammation |
| 04/20/2010 | US7700315 Comprises nucleotide sequences coding polypeptide with serine protease activity for use in identifying modulator and treaments for blood coagulation and cell proliferative disorders |
| 04/20/2010 | US7700314 Method for producing polyol-IFN-β conjugate |
| 04/20/2010 | US7700301 Using protein tyrosine phosphatase (SHP-2) as tool in identifying compounds which modulate the activity of programed death-1 (PD-1); treating autoimmune, nervous system, tumor and immunosuppressive disorders |
| 04/20/2010 | US7700109 Biomolecule transduction motif Mph-1-BTM and the use thereof |
| 04/20/2010 | US7700107 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid β for induction of an immune response to amyloid β and amyloid deposits |
| 04/20/2010 | US7700100 FcγRIIB fusion proteins and compositions thereof |
| 04/20/2010 | US7700092 Pneumovirus NS proteins antagonize the interferon IFN response |
| 04/20/2010 | US7700087 Compounds and methods to inhibit or augment an inflammatory response |
| 04/20/2010 | CA2572898C Composition for the prevention and treatment of allergic inflammatory disease |
| 04/20/2010 | CA2448356C N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 04/20/2010 | CA2388240C Phenoxy carboxylic acid compounds and compositions for delivering active agents |
| 04/20/2010 | CA2361587C Methods and compositions to enhance white blood cell count |
| 04/20/2010 | CA2352572C Humanized antibodies to gamma-interferon |
| 04/20/2010 | CA2219876C Stable variant hk2 polypeptide |
| 04/20/2010 | CA2180872C Composition containing nucleic acids, preparation and uses |
| 04/20/2010 | CA2179779C Vaccine compositions comprising oil in water emulsions with tocopherol and squalene |
| 04/15/2010 | WO2010042644A2 Methods for inducing a sustained immune response againts a b-cell idiotype using autologous anti-idiotypic vaccines |
| 04/15/2010 | WO2010041684A1 Tacrolimus preparation for external applications |
| 04/15/2010 | WO2010041449A1 Anti-allergic agent comprising rxr agonist as active ingredient |
| 04/15/2010 | WO2010041143A2 Oral vaccines for producing mucosal immunity |
| 04/15/2010 | WO2010040209A1 Methods and systems for predicting misfolded protein epitopes |
| 04/15/2010 | WO2010019611A3 Bridged polycyclic compound based compositions for topical and oral applications |
| 04/15/2010 | WO2010018837A3 Protein cross-linking inhibitor |
| 04/15/2010 | WO2010018836A3 Polyglutamine aggregation inhibitor |
| 04/15/2010 | WO2010006169A3 2-methylene-19, 26-dinor-(20s, 22e, 25r)-vitamin d analogs |
| 04/15/2010 | WO2010006135A3 2-methylene-(17z)-17(20)-dehydro-19,21-dinor-vitamin d analogs |
| 04/15/2010 | WO2010004052A3 Agonists of nr2f6 for immunosuppression |
| 04/15/2010 | WO2010003127A3 Antagonists of prostaglandin d2 receptors |
| 04/15/2010 | WO2010000903A3 Composition capable of modulating ikkalpha activity for the treatment of diseases associated with acantholysis |
| 04/15/2010 | WO2009139655A3 The use of an exopolysaccharide fraction produced by Lactobacillus rhamnosus |
| 04/15/2010 | WO2009071753A8 4-phenyl-1,3-thiazole and 4-phenyl-1,3-oxazole derivatives as cannabinoid receptor ligands |
| 04/15/2010 | US20100094003 Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases |
| 04/15/2010 | US20100093862 Potentiation of cellular immunity using histone deacetylase (hdac) inhibitors. |
| 04/15/2010 | US20100093806 Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogs |
| 04/15/2010 | US20100093802 Ccr9 inhibitors and methods of use thereof |
| 04/15/2010 | US20100093774 5-substituted quinazolinone derivatives and compositions comprising and methods of using the same |
| 04/15/2010 | US20100093767 Mitotic Kinase Inhibitors |
| 04/15/2010 | US20100093749 Compounds |
| 04/15/2010 | US20100093713 Beta-carbolines useful for treating inflammatory disease |
| 04/15/2010 | US20100093690 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
| 04/15/2010 | US20100093649 Synthetic glycolipid analogues and derivatives for the treatment of pathologic disorders |
| 04/15/2010 | US20100093639 Transport Molecules Using Reverse Sequence HIV-TAT Polypeptides |
| 04/15/2010 | US20100093632 Enamel matrix protein composition for treatment of systemic inflammatory response |
| 04/15/2010 | US20100093627 Albumin fusion proteins |
| 04/15/2010 | US20100093611 Compounds and methods for treating or preventing autoimmune diseases |
| 04/15/2010 | US20100092997 Method of Enhancing of Binding Activity of Antibody Composition to FcGamma Receptor IIIa |
| 04/15/2010 | US20100092569 Product based on conjugated linoleic acid and a method for the manufacture thereof |
| 04/15/2010 | US20100092562 Sustained-release drug delivery compositions and methods |
| 04/15/2010 | US20100092513 Methods and compositions for inducing an immune response to HIV and models for testing |
| 04/15/2010 | US20100092505 Method for Shielding Functional Sites or Epitopes on Proteins |
| 04/15/2010 | US20100092502 Modified hiv env polypeptides |
| 04/15/2010 | US20100092488 Method for Treatment or Prevention of Disease Associated Wtih Functional Disorder of Regulatory T Cell |
| 04/15/2010 | US20100092487 Toxic detection method |
| 04/15/2010 | US20100092486 Modulation of myeloid differentation primary response gene 88 (myd88) expression by antisense oligonucleotides |
| 04/15/2010 | US20100092484 Cd44 antibodies |
| 04/15/2010 | US20100092472 Compounds and methods for the modulation of beta-1 integrin function to mediate tissue repair |
| 04/15/2010 | US20100092465 Treatment of graft-versus-host disease |
| 04/15/2010 | US20100092460 Amino acid sequences directed against chemokines and polypeptides comprising the same for the treatment of chemokine-related diseases and disorders |
| 04/15/2010 | US20100092448 Local control of inflammation |
| 04/15/2010 | US20100092445 Adoptive immune cells for tumor vaccines |
| 04/15/2010 | US20100092444 Platelet rich plasma formulations for cardiac treatments |
| 04/15/2010 | US20100092436 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
| 04/15/2010 | US20100092435 Use of a varicellovirus tap-inhibitor for the induction of tumor-or virus-specific immunity against teipp |
| 04/15/2010 | US20100092429 Composition |
| 04/15/2010 | US20100092423 Pharmaceutical composition comprising an anti-cd6 monoclonal antibody used in the diagnosis and treatment of rheumatoid arthritis |
| 04/15/2010 | US20100092401 Immune response modifier formulations |
| 04/15/2010 | CA2743361A1 Methods and systems for predicting misfolded protein epitopes |
| 04/15/2010 | CA2739918A1 Methods for inducing a sustained immune response against a b-cell idiotype using autologous anti-idiotypic vaccines |
| 04/15/2010 | CA2738831A1 Tacrolimus preparation for external applications |
| 04/15/2010 | CA2737684A1 Oral vaccines for producing mucosal immunity |
| 04/14/2010 | EP2174955A1 Ifnar2 muteins, their production and use |
| 04/14/2010 | EP2174949A2 Leucine-based motif and clostridial neurotoxins |
| 04/14/2010 | EP2174939A1 Pyranones useful as ATM inhibitors |
| 04/14/2010 | EP2174665A2 Compositions and methods for activating innate and allergic immunity |
| 04/14/2010 | EP2174139A1 Method for testing a subject thought to have or to be predisposed to asthma |
| 04/14/2010 | EP2173902A1 Therapeutics and diagnostics for group a streptococci |
| 04/14/2010 | EP2173876A2 T-cell cytokine-inducing surface molecules and methods of use |
| 04/14/2010 | EP2173714A1 Piperidine derivatives as modulators of chemokine receptor activity |
| 04/14/2010 | EP2173713A2 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 04/14/2010 | EP2173351A2 Compounds and methods for treatment of sickle cell disease or complications associated therewith |
| 04/14/2010 | EP1786439B1 Methods of activating nkt cells |
| 04/14/2010 | EP1627871B1 Cyclic aminophenyl sulfamate derivative |
| 04/14/2010 | EP1477482B1 Novel phenylalanine derivative |
| 04/14/2010 | EP1409016B1 Antibodies to opgl |
| 04/14/2010 | EP1406928B1 Ntb-a, a surface molecule involved in natural killer cells activity |
| 04/14/2010 | EP1400515B1 Cyclic diamine compound having five-membered cyclic group |
| 04/14/2010 | EP1347773B1 Compositions and methods for enhancing cytokine activity and treating hypotension associated with the administration of cytokines |
| 04/14/2010 | EP1221969B1 Activation of antigen-specific t cells by virus/antigen-treated dendritic cells |
| 04/14/2010 | CN1935230B Chinese medicine injection preparation and its preparing method |
| 04/14/2010 | CN1778296B Long-acting preparation for tatin medicine |
| 04/14/2010 | CN101693890A Immunostimulatory sequence oligonucleotides and methods of using the same |
| 04/14/2010 | CN101693865A Mulberry leaf pure wine and production process thereof |
| 04/14/2010 | CN101693674A Oxime compound, preparation process and application thereof |
| 04/14/2010 | CN101693109A Yeast glucan synergistic inactivated vaccine for preventing staphylococcus aureus mastitis in dairy cows |
| 04/14/2010 | CN101693105A Application of IL-4-like recombinant protein of fishes |